CAR NK cell therapy is a novel immunotherapy made from natural killer (NK) cells engineered to better recognize and eliminate cancer cells  At UT MD Anderson, CAR NK cell therapies are created from NK cells collected from donated umbilical cord blood   MD Anderson researchers identified a small population of immature NK cells associated with poorer treatment outcomes  These immature cells can pick up cancer proteins through a … Continue reading Donor cord blood composition may influence CAR NK cell therapy outcomes